• Datametrex (DM) has announced a new milestone with its Medi-Call telehealth business
  • Medi-Call will begin to take live telehealth patient requests via the mobile application beginning on May 24, 2022
  • The company is also announcing that Andrew Ryu has stepped down as Director and Executive Chairman with Director Paul Haber taking his place
  • Datametrex develops AI-powered solutions for cyber security, telehealth and electric vehicles
  • Datametrex (DM) is down by 3.23 per cent trading at $0.15 per share

Datametrex (DM) has announced a new milestone with its Medi-Call telehealth business.

Medi-Call will begin to take live telehealth patient requests via the mobile application beginning on May 24, 2022.

Medi-Call is a subscription-based mobile app that connects patients with doctors in real time.

It increases medical accessibility for patients with limited mobility or who live in rural or isolated communities.

“We are excited with the progress we’ve made with Medi-Call and cannot wait to begin bringing it to more patients in need of direct health care, both in person and through telemedicine,” said Omar Sharif, President of Medi-Call.

The company is also announcing that Andrew Ryu has stepped down as Director and Executive Chairman for personal reasons. Director Paul Haber has been appointed in his place.

Datametrex develops AI-powered solutions for cyber security, telehealth and electric vehicles.

Datametrex (DM) is down by 3.23 per cent trading at $0.15 per share as of 10:06 am EST.

More From The Market Online

Liberty Defense expands its international customer base

Liberty Defense Holdings (TSXV:SCAN), a provider of artificial intelligence technologies, expands its international customer base.

Unsung profits: Three microcap stocks with a strong case for value

A key factor behind picking winning microcap value stocks is identifying dislocations between company performance and market perception.

Theralase advances cancer research after private placement

Theralase Technologies (TSXV:TLT) closes a non-brokered private placement offering of 4.1 million shares for gross proceeds of C$750,200.